Home
News Detail

GlaxoSmithKline promises to invest $30 billion in the United States as Trump arrives in the UK

Source: CoinWorld
GlaxoSmithKline promises to invest $30 billion in the United States over the next five years, coincides with President Trump's state visit to the UK. Previously, other pharmaceutical companies made similar promises after Trump threatened to impose tariffs on imported drugs and criticized the high U.S. drug prices. The U.S. market accounts for about 50% of GlaxoSmithKline's total revenue.
Link copied to clipboard